| scholarly article | Q13442814 |
| P50 | author | Susan C. Baker | Q19865464 |
| Andrew D. Mesecar | Q38317666 | ||
| Xufang Deng | Q90539286 | ||
| Anna M. Mielech | Q114448715 | ||
| Yahira M Báez-Santos | Q114448720 | ||
| P2860 | cites work | Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia | Q24558699 |
| Middle East respiratory syndrome coronavirus in bats, Saudi Arabia | Q24596439 | ||
| Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential | Q24620245 | ||
| PHENIX: a comprehensive Python-based system for macromolecular structure solution | Q24654617 | ||
| Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities | Q26825953 | ||
| Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological Evaluation | Q27662127 | ||
| Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells | Q27676341 | ||
| X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases | Q27681891 | ||
| Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease | Q27683898 | ||
| Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease | Q27689096 | ||
| Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features | Q27694423 | ||
| Coot: model-building tools for molecular graphics | Q27860505 | ||
| SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon | Q38008817 | ||
| MERS-CoV papain-like protease has deISGylating and deubiquitinating activities | Q38315802 | ||
| Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. | Q39349816 | ||
| Structure and recognition of polyubiquitin chains of different lengths and linkage | Q39553217 | ||
| Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling | Q39860643 | ||
| PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production | Q39924024 | ||
| The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity | Q40670135 | ||
| Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. | Q42251659 | ||
| Effects of coronavirus infections in children | Q42407764 | ||
| Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease | Q42628710 | ||
| Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme | Q44246327 | ||
| Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus. | Q44594725 | ||
| A new virus isolated from the human respiratory tract | Q45825116 | ||
| Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition | Q46617455 | ||
| Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. | Q51036588 | ||
| No novel coronaviruses identified in a large collection of human nasopharyngeal specimens using family-wide CODEHOP-based primers. | Q54288328 | ||
| Severe acute respiratory syndrome | Q56775278 | ||
| Clusters of coronavirus cases put scientists on alert | Q59098160 | ||
| Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia | Q85904728 | ||
| Breaking the chains: structure and function of the deubiquitinases | Q28131738 | ||
| Characterization of a novel coronavirus associated with severe acute respiratory syndrome | Q28202401 | ||
| The ubiquitin code | Q28265104 | ||
| Yeast based small molecule screen for inhibitors of SARS-CoV | Q28478245 | ||
| The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme | Q28768791 | ||
| Identification of a new human coronavirus | Q29615906 | ||
| Identification of a novel coronavirus in patients with severe acute respiratory syndrome | Q29615907 | ||
| The Genome sequence of the SARS-associated coronavirus | Q29619007 | ||
| Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? | Q30223960 | ||
| Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. | Q30351904 | ||
| PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway | Q31001219 | ||
| A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication | Q33375590 | ||
| Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease | Q33488957 | ||
| Hospital outbreak of Middle East respiratory syndrome coronavirus | Q33642332 | ||
| Coronaviruses post-SARS: update on replication and pathogenesis | Q33694361 | ||
| Identification of mouse hepatitis virus papain-like proteinase 2 activity | Q33810527 | ||
| Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. | Q33826676 | ||
| Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling | Q34152661 | ||
| The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. | Q34457606 | ||
| Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme | Q34595903 | ||
| Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications | Q34780031 | ||
| The emerging complexity of protein ubiquitination | Q35002957 | ||
| Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease | Q35074220 | ||
| Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? | Q35097505 | ||
| Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. | Q35239001 | ||
| Comparison of SARS and NL63 papain-like protease binding sites and binding site dynamics: inhibitor design implications | Q36095703 | ||
| Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans | Q36432023 | ||
| Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease | Q36465731 | ||
| Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. | Q36673320 | ||
| IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding | Q37245607 | ||
| Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors | Q37252823 | ||
| Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus | Q37372586 | ||
| Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study | Q37504790 | ||
| Replicative Capacity of MERS Coronavirus in Livestock Cell Lines | Q37513472 | ||
| Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity | Q37683240 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular biology | Q7202 |
| Coronaviridae | Q1134583 | ||
| Middle East respiratory syndrome coronavirus | Q4902157 | ||
| Middle East respiratory syndrome | Q16654806 | ||
| P304 | page(s) | 12511-12527 | |
| P577 | publication date | 2014-08-20 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus | |
| P478 | volume | 88 |
| Q40839354 | A 5'-proximal region of the Citrus tristeza virus genome encoding two leader proteases is involved in virus superinfection exclusion |
| Q40207077 | A Naturally Occurring Recombinant Enterovirus Expresses a Torovirus Deubiquitinase |
| Q38703304 | A molecular arms race between host innate antiviral response and emerging human coronaviruses |
| Q111911193 | An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 |
| Q84315407 | Analysis of Coronavirus Temperature-Sensitive Mutants Reveals an Interplay between the Macrodomain and Papain-Like Protease Impacting Replication and Pathogenesis |
| Q89973070 | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
| Q90312549 | COVID-19 spike-host cell receptor GRP78 binding site prediction |
| Q95309312 | Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease |
| Q110653032 | Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs |
| Q34683256 | Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression |
| Q93180376 | Drug Development and Medicinal Chemistry Efforts Toward SARS-Coronavirus and Covid-19 Therapeutics |
| Q91912060 | Emerging Developments on Pathogenicity, Molecular Virulence, Epidemiology and Clinical Symptoms of Current Middle East Respiratory Syndrome Coronavirus (MERS-CoV) |
| Q36694030 | Extensive Positive Selection Drives the Evolution of Nonstructural Proteins in Lineage C Betacoronaviruses |
| Q88701533 | ISG15 in antiviral immunity and beyond |
| Q89830480 | Identification of a novel base J binding protein complex involved in RNA polymerase II transcription termination in trypanosomes |
| Q104529925 | Imperfect innate immune antagonism renders SARS-CoV-2 vulnerable towards IFN-γ and -λ |
| Q58595060 | MERS coronavirus outbreak: Implications for emerging viral infections |
| Q30248743 | MERS-CoV spike protein: Targets for vaccines and therapeutics |
| Q34468689 | Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease |
| Q26796501 | Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control |
| Q47413440 | Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein |
| Q36923194 | Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease |
| Q90720676 | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study |
| Q35660049 | SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme |
| Q104439997 | SARS-CoV-2 proteases cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species and the search for reservoir hosts |
| Q104583499 | Spatial and temporal roles of SARS-CoV PLpro -A snapshot |
| Q38733340 | Steady-state kinetic studies reveal that the anti-cancer target Ubiquitin-Specific Protease 17 (USP17) is a highly efficient deubiquitinating enzyme |
| Q40229759 | Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species. |
| Q90678869 | Structural and biochemical characterization of SADS-CoV papain-like protease 2 |
| Q27707324 | Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin |
| Q104468598 | Structural basis for the inhibition of the papain-like protease of SARS-CoV-2 by small molecules |
| Q30153246 | Structural view and substrate specificity of papain-like protease from avian infectious bronchitis virus |
| Q41933440 | Structurally guided removal of deISGylase biochemical activity from papain-Like protease originating from the Middle East Respiratory Syndrome Virus. |
| Q39381317 | Structure and Function of Viral Deubiquitinating Enzymes. |
| Q104512144 | Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors |
| Q107011723 | Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors |
| Q90437491 | Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus |
| Q108396361 | Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities |
| Q30370367 | The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. |
| Q106996591 | The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery |
| Q91473752 | The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection |
| Q107102118 | The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication |
| Q58494157 | The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species |
| Q36283285 | X-ray Structural and Functional Studies of the Three Tandemly Linked Domains of Non-structural Protein 3 (nsp3) from Murine Hepatitis Virus Reveal Conserved Functions |
| Q37581697 | X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design |
| Q37258617 | p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1 |
Search more.